Will Novavax ETFs Gain On Coronavirus Vaccine Progress?
September 05, 2020 at 18:50 PM EDT
Novavax (NVAX) is a formidable name in the list of companies who are working on a vaccine. The company’s shares have gained 2487.4% this year. Let’s look at ETFs with the highest exposure to Novarax that can gain on the positive development,